<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="31/10/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8449904" creator="Yo Shidahara">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8449904</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Other" id="T1" lex="transcriptional_regulation">Transcriptional regulation</term> of the <term sem="DNA_domain_or_region" id="T2" lex="pyruvate_kinase_erythroid-specific_promoter">pyruvate kinase erythroid-specific promoter</term>.</sentence>
<event id="E1">
<type class="Regulation" />
<theme idref="T2" />
<clue><clueType>Transcriptional regulation</clueType> <linkTheme>of</linkTheme> the pyruvate kinase erythroid-specific promoter.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Protein_family_or_group" id="T3" lex="mammal_pyruvate_kinases">Mammal pyruvate kinases</term> are encoded by two genes.</sentence>
<sentence id="S3">The <term sem="DNA_domain_or_region" id="T4" lex="L_gene">L gene</term> produces the <term sem="Protein_molecule" id="T5" lex="erythroid_isozyme">erythroid</term> (<term sem="Protein_molecule" id="T6" lex="R-PK">R-PK</term>) or the <term sem="Protein_molecule" id="T7" lex="hepatic_(L-PK)_isozyme">hepatic (<term sem="Protein_molecule" id="T8" lex="L-PK">L-PK</term>) isozymes</term> by the alternative use of two <term sem="DNA_domain_or_region" id="T9" lex="promoter">promoters</term>.</sentence>
<event id="E2">
<type class="Gene_expression" />
<theme idref="T6" />
<clue>The L gene <clueType>produces</clueType> the erythroid (R-PK) or the hepatic (L-PK) isozymes by the alternative use of two promoters.</clue>
</event>
<event id="E3">
<type class="Gene_expression" />
<theme idref="T8" />
<clue>The L gene <clueType>produces</clueType> the erythroid (R-PK) or the hepatic (L-PK) isozymes by the alternative use of two promoters.</clue>
</event>
<event id="E4">
<type class="Positive_regulation" />
<theme idref="E2" />
<cause idref="T9" />
<clue>The L gene produces the erythroid (R-PK) or the hepatic (L-PK) isozymes <linkCause>by the alternative use of</linkCause> two promoters.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="E3" />
<cause idref="T9" />
<clue>The L gene produces the erythroid (R-PK) or the hepatic (L-PK) isozymes <linkCause>by the alternative use of</linkCause> two promoters.</clue>
<comment>NO CLUETYPE</comment>
</event>
<sentence id="S4">We report the characterization of the <cons sem="(AND DNA_domain_or_region DNA_domain_or_region)" id="T10" lex="(AND cis-acting_element trans-acting_element)"><frag id="F1"><term sem="DNA_domain_or_region" id="A1">cis-</term></frag> and <frag id="F2"><term sem="DNA_domain_or_region" id="A2">trans-</term></frag><frag id="F3"><term sem="DNA_domain_or_region" id="A3">acting elements</term></frag></cons> involved in the tissue-specific activity of the <term sem="DNA_domain_or_region" id="T11" lex="L_gene_erythroid_promoter">L gene erythroid promoter</term>.</sentence>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="T11" />
<clue>We report the characterization of the cis- and trans-acting elements involved in the <clueLoc>tissue-specific</clueLoc> <clueType>activity</clueType> <linkTheme>of</linkTheme> the L gene erythroid promoter.</clue>
</event>
<event id="E7">
<type class="Correlation" />
<theme idref="E6" />
<theme idref1="A3" idref="A1" />
<clue>We report the characterization of the cis- and trans-acting elements <clueType>involved</clueType> <linkTheme>in</linkTheme> the tissue-specific activity of the L gene erythroid promoter.</clue>
</event>
<event id="E8">
<type class="Correlation" />
<theme idref="E6" />
<theme idref1="A3" idref="A2" />
<clue>We report the characterization of the cis- and trans-acting elements <clueType>involved</clueType> <linkTheme>in</linkTheme> the tissue-specific activity of the L gene erythroid promoter.</clue>
</event>
<sentence id="S5">A <term sem="DNA_molecule" id="T12" lex="R-PK_DNA_fragment">R-PK DNA fragment</term> extending from -870 to +54 relative to the <term sem="DNA_domain_or_region" id="T13" lex="cap_site">cap site</term> confers <term sem="Cell_natural" id="A5">erythroid</term> specificity to a <term sem="DNA_family_or_group" id="T14" lex="reporter_gene">reporter gene</term>.</sentence>
<event id="E9">
<type class="Positive_regulation" />
<theme idref="T14" />
<clue>A R-PK DNA fragment extending from -870 to +54 relative to the cap site confers <clueLoc>erythroid</clueLoc> <clueType>specificity</clueType> <linkTheme>to</linkTheme> a reporter gene.</clue>
</event>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="E9" />
<cause idref="T12" />
<clue>A R-PK DNA fragment extending from -870 to +54 relative to the cap site <clueType>confers</clueType> erythroid specificity to a reporter gene.</clue>
</event>
<sentence id="S6">Within this region, we define a <term sem="DNA_domain_or_region" id="T15" lex="minimal_promoter">minimal promoter</term> (-62 to +54) that displays <term sem="Other" id="T16" lex="erythroid-specific_activity"><term sem="Cell_natural" id="A6">erythroid</term>-specific activity</term> and contains two <term sem="DNA_domain_or_region" id="A7">DNA binding sites</term>.</sentence>
<event id="E11">
<type class="Positive_regulation" />
<theme idref="T15" />
<clue>Within this region, we define a minimal promoter (-62 to +54) that <clueType>displays</clueType> <clueLoc>erythroid-specific</clueLoc> <clueType>activity</clueType> and contains two DNA binding sites.</clue>
</event>
<sentence id="S7">One, located at -50, binds members of the <term sem="Protein_family_or_group" id="T17" lex="CCACC/Sp1_family">CCACC/Sp1 family</term> and the other, located at -20, binds the <term sem="Protein_molecule" id="T18" lex="erythroid_factor_GATA-1">erythroid factor GATA-1</term>.</sentence>
<event id="E12">
<type class="Binding" />
<theme idref="T15" />
<theme idref="T17" />
<clue><corefTheme>One, located at -50</corefTheme>, <clueType>binds</clueType> members of the CCACC/Sp1 family and the other, located at -20, binds the erythroid factor GATA-1.</clue>
</event>
<event id="E13">
<type class="Binding" />
<theme idref="T15" />
<theme idref="T18" />
<clue>One, located at -50, binds members of the CCACC/Sp1 family and <corefTheme>the other, located at -20</corefTheme>, <clueType>binds</clueType> the erythroid factor GATA-1.</clue>
</event>
<sentence id="S8">Although the -20 <term sem="DNA_domain_or_region" id="T19" lex="GATA_binding_site">GATA binding site</term> (<term sem="Polynucleotide" id="T20" lex="AGATAA">AGATAA</term>) is also a potential <term sem="DNA_domain_or_region" id="T21" lex="TFIID_binding_site">TFIID binding site</term>, it does not bind <term sem="Protein_molecule" id="T22" lex="TFIID">TFIID</term>.</sentence>
<event assertion="non-exist" id="E14">
<type class="Binding" />
<theme idref="T19" />
<theme idref="T22" />
<clue>Although the -20 GATA binding site (AGATAA) is also a potential TFIID binding site, <corefTheme>it</corefTheme> does not <clueType>bind</clueType> TFIID.</clue>
</event>
<sentence id="S9">Furthermore, the substitution of this <term sem="DNA_domain_or_region" id="T23" lex="GATA_binding_site">GATA binding site</term> by a canonical <term sem="DNA_domain_or_region" id="T24" lex="TFIID_binding_site"><term sem="Protein_molecule" id="T25" lex="TFIID">TFIID</term> binding site</term> suppresses the promoter activity.</sentence>
<event id="E15">
<type class="Artificial_process" />
<theme idref="T23" />
<theme idref="T24" />
<clue>Furthermore, the <clueType>substitution</clueType> <linkTheme>of</linkTheme> this GATA binding site <linkTheme>by</linkTheme> a canonical TFIID binding site suppresses the promoter activity.</clue>
</event>
<event id="E16">
<type class="Negative_regulation" />
<theme idref="T15" />
<cause idref="E15" />
<clue>Furthermore, the substitution of this GATA binding site by a canonical TFIID binding site <clueType>suppresses</clueType> the promoter activity.</clue>
</event>
<sentence id="S10">Mutations and deletions of both sites indicate that only the association of <term sem="DNA_domain_or_region" id="T26" lex="CCACC/Sp1">CCACC/Sp1</term> and <term sem="DNA_domain_or_region" id="T27" lex="GATA_binding_site">GATA binding</term> <term sem="DNA_domain_or_region" id="A34">sites</term> can drive efficient and tissue-specific expression of this <term sem="DNA_domain_or_region" id="T29" lex="minimal_promoter"><term sem="Protein_molecule" id="T28" lex="R-PK">R-PK</term> minimal promoter</term>.</sentence>
<event id="E17">
<type class="Binding" />
<theme idref1="A34" idref="T26" />
<clue>Mutations and deletions of both sites indicate that only the <clueType>association</clueType> <linkTheme>of</linkTheme> CCACC/Sp1 and GATA binding sites can drive efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
<comment>NER T26, T27, T29 MOD, OKAP &quot;another THEME is not mentioned&quot;</comment>
</event>
<event id="E117">
<type class="Binding" />
<theme idref1="A34" idref="T27" />
<clue>Mutations and deletions of both sites indicate that only the <clueType>association</clueType> <linkTheme>of</linkTheme> CCACC/Sp1 and GATA binding sites can drive efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
<comment>OKAP &quot;another THEME is not mentioned&quot;</comment>
</event>
<event id="E18">
<type class="Gene_expression" />
<theme idref="T29" />
<clue>Mutations and deletions of both sites indicate that only the association of CCACC/Sp1 and GATA binding sites can drive efficient and <clueLoc>tissue-specific</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> this R-PK minimal promoter.</clue>
</event>
<event id="E19">
<type class="Positive_regulation" />
<theme idref="E18" />
<cause idref="E17" />
<clue><clueExperiment>Mutations and deletions of both sites</clueExperiment> indicate that only the association of CCACC/Sp1 and GATA binding sites can <clueType>drive</clueType> efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
</event>
<event id="E119">
<type class="Positive_regulation" />
<theme idref="E18" />
<cause idref="E117" />
<clue><clueExperiment>Mutations and deletions of both sites</clueExperiment> indicate that only the association of CCACC/Sp1 and GATA binding sites can <clueType>drive</clueType> efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
</event>
<event id="E219">
<type class="Mutagenesis" />
<theme idref1="A34" idref="T26" />
<clue><clueType>Mutations</clueType> and deletions <linkTheme>of</linkTheme> <corefTheme>both sites</corefTheme> indicate that only the association of CCACC/Sp1 and GATA binding sites can drive efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
</event>
<event id="E120">
<type class="Mutagenesis" />
<theme idref1="A34" idref="T27" />
<clue><clueType>Mutations</clueType> and deletions <linkTheme>of</linkTheme> <corefTheme>both sites</corefTheme> indicate that only the association of CCACC/Sp1 and GATA binding sites can drive efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
</event>
<event id="E121">
<type class="Negative_regulation" />
<theme idref1="A34" idref="T26" />
<clue>Mutations and <clueType>deletions</clueType> <linkTheme>of</linkTheme> <corefTheme>both sites</corefTheme> indicate that only the association of CCACC/Sp1 and GATA binding sites can drive efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
<comment>ARTIFICIAL</comment>
</event>
<event id="E122">
<type class="Negative_regulation" />
<theme idref1="A34" idref="T27" />
<clue>Mutations and <clueType>deletions</clueType> <linkTheme>of</linkTheme> <corefTheme>both sites</corefTheme> indicate that only the association of CCACC/Sp1 and GATA binding sites can drive efficient and tissue-specific expression of this R-PK minimal promoter.</clue>
<comment>ARTIFICIAL</comment>
</event>
<sentence id="S11">Finally, by <term sem="Other" id="T30" lex="co-transfection_experiment">co-transfection experiments</term>, we study the <term sem="DNA_domain_or_region" id="T34">elements</term> involved in the <term sem="Other" id="T31" lex="hGATA-1_transactivation"><term sem="Protein_molecule" id="A10">hGATA-1</term> transactivation</term> of the <term sem="DNA_domain_or_region" id="T32" lex="R-PK_promoter">R-PK promoter</term> in <term sem="Cell_cultured" id="T33" lex="HeLa_cells">HeLa cells</term>.</sentence>
<event id="E20">
<type class="Positive_regulation" />
<theme idref="T32" />
<cause idref="A10" />
<clue>Finally, by co-transfection experiments, we study the elements involved in the hGATA-1 <clueType>transactivation</clueType> <linkTheme>of</linkTheme> the R-PK promoter in HeLa cells.</clue>
</event>
<event id="E21">
<type class="Correlation" />
<theme idref="T34" />
<theme idref="E20" />
<clue>Finally, <clueExperiment>by co-transfection experiments</clueExperiment>, we study the elements <clueType>involved</clueType> <linkTheme>in</linkTheme> the hGATA-1 transactivation of the R-PK promoter <clueLoc>in HeLa cells</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
